Frank Weathers, PhD

Publications

• Published 11/14/2024

  Lee DJ, Weathers FW, Bovin MJ, Marx BP. On the concordance between CAPS-5 and PCL-5 scores. Eur J Psychotraumatol. 2024; 15(1):2407728. PMID: 39539241.

  Read at: PubMed

• Published 8/28/2024

  Reid MA, Whiteman SE, Camden AA, Jeffirs SM, Weathers FW. Prefrontal Metabolite Alterations in Individuals with Posttraumatic Stress Disorder: A 7T Magnetic Resonance Spectroscopy Study. Chronic Stress (Thousand Oaks). 2024; 8:24705470241277451. PMID: 39253023.

  Read at: PubMed

• Published 8/23/2024

  Jackson BN, Weathers FW, Jeffirs SM, Preston TJ, Brydon CM. The revised Clinician-Administered PTSD scale for DSM-5 (CAPS-5-R): Initial psychometric evaluation in a trauma-exposed community sample. J Trauma Stress. 2025 Feb; 38(1):40-52. PMID: 39176447.

  Read at: PubMed

• Published 7/18/2024

  Reid MA, Whiteman SE, Camden AA, Jeffirs SM, Weathers FW. Prefrontal metabolite alterations in individuals with posttraumatic stress disorder: a 7T magnetic resonance spectroscopy study. bioRxiv. 2024 Jul 18. PMID: 39071259.

  Read at: PubMed

• Published 2/1/2024

  Parmenter ME, Lederman S, Weathers FW, Davis LL, Vaughn B, Engels J, Sullivan GM. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry Res. 2024 Apr; 334:115764. PMID: 38350291.

  Read at: PubMed

View All 73 Publications:   View Full Profile in BUMC